Bredt David
SEC insider (Form 3/4/5 filer). CIK 0002022087. Chief Scientific Officer at Rapport Therapeutics, Inc. (RAPP). 25 reported Form 4/5 transactions since Sep 2024; latest on Feb 19, 2026. Located in BOSTON, MA.
Companies Bredt David has filed insider reports for
- Rapport Therapeutics, Inc. (RAPP): Officer, Chief Scientific Officer
Bredt David
CIK: 0002022087
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Rapport Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (25 total)
- Feb 19, 2026RAPP
Rapport Therapeutics, Inc.
ExerciseDirect6K shares at avg. $1.80$11K - Feb 17, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect900 shares at avg. $28.02$25K - Feb 17, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect2.2K shares at avg. $29.59$65K - Feb 17, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect5.4K shares at avg. $28.95$156K - Feb 2, 2026RAPP
Rapport Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
103K shares- - Jan 15, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect8.3K shares at avg. $26.83$223K - Jan 15, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect200 shares at avg. $27.40$5K - Dec 31, 2025RAPP
Rapport Therapeutics, Inc.
AwardDirect18K shares- - Dec 31, 2025RAPP
Rapport Therapeutics, Inc.
SaleDirect6.6K shares at avg. $30.05$197K - Dec 15, 2025RAPP
Rapport Therapeutics, Inc.
SaleDirect796 shares at avg. $30.68$24K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 19, 2026 | RAPP Rapport Therapeutics, Inc. | Exercise | 6,000 | $1.80 | $10,800 | Direct |
| Feb 17, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 900 | $28.02 | $25,219 | Direct |
| Feb 17, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 2,200 | $29.59 | $65,108 | Direct |
| Feb 17, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 5,400 | $28.95 | $156,328 | Direct |
| Feb 2, 2026 | RAPP Rapport Therapeutics, Inc. | Award Stock Option (Right to Buy) | 103,000 | - | - | Direct |
| Jan 15, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 8,300 | $26.83 | $222,652 | Direct |
| Jan 15, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 200 | $27.40 | $5,480 | Direct |
| Dec 31, 2025 | RAPP Rapport Therapeutics, Inc. | Award | 18,000 | - | $0 | Direct |
| Dec 31, 2025 | RAPP Rapport Therapeutics, Inc. | Sale | 6,567 | $30.05 | $197,338 | Direct |
| Dec 15, 2025 | RAPP Rapport Therapeutics, Inc. | Sale | 796 | $30.68 | $24,419 | Direct |
1-10 of 25 transactions